Your browser doesn't support javascript.
loading
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Badio, Moses; Lhomme, Edouard; Kieh, Mark; Beavogui, Abdoul Habib; Kennedy, Stephen B; Doumbia, Seydou; Leigh, Bailah; Sow, Samba O; Diallo, Alpha; Fusco, Daniela; Kirchoff, Matthew; Termote, Monique; Vatrinet, Renaud; Wentworth, Deborah; Esperou, Helène; Lane, H Clifford; Pierson, Jerome; Watson-Jones, Deborah; Roy, Céline; D'Ortenzio, Eric; Greenwood, Brian; Chêne, Genevieve; Richer, Laura; Neaton, James D; Yazdanpanah, Yazdan.
Afiliação
  • Badio M; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
  • Lhomme E; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
  • Kieh M; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
  • Beavogui AH; Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea.
  • Kennedy SB; Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
  • Doumbia S; University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
  • Leigh B; College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
  • Sow SO; Centre pour le Développement des Vaccins, Bamako, Mali.
  • Diallo A; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
  • Fusco D; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
  • Kirchoff M; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Termote M; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
  • Vatrinet R; REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.
  • Wentworth D; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  • Esperou H; INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
  • Lane HC; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Pierson J; National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Watson-Jones D; London School of Hygiene & Tropical Medicine, London, UK.
  • Roy C; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
  • D'Ortenzio E; REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.
  • Greenwood B; AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France.
  • Chêne G; London School of Hygiene & Tropical Medicine, London, UK.
  • Richer L; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
  • Neaton JD; Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
  • Yazdanpanah Y; Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Trials ; 22(1): 583, 2021 Sep 01.
Article em En | MEDLINE | ID: mdl-34470655

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Libéria

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Libéria